Literature DB >> 15867822

Chemotherapy in non-small cell lung cancer: an update of an individual patient data-based meta-analysis.

Sarah Burdett, Lesley Stewart, Jean-Pierre Pignon.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 15867822     DOI: 10.1016/j.jtcvs.2004.12.032

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  12 in total

Review 1.  Targeted therapy in non-small-cell lung cancer--is it becoming a reality?

Authors:  Filip Janku; David J Stewart; Razelle Kurzrock
Journal:  Nat Rev Clin Oncol       Date:  2010-06-15       Impact factor: 66.675

Review 2.  Management of non-small cell lung cancer with oligometastasis.

Authors:  Liza C Villaruz; Gregory J Kubicek; Mark A Socinski
Journal:  Curr Oncol Rep       Date:  2012-08       Impact factor: 5.075

Review 3.  Personalized therapy for non-small cell lung cancer: which drug for which patient?

Authors:  Liza C Villaruz; Mark A Socinski
Journal:  Semin Thorac Cardiovasc Surg       Date:  2011

4.  Optimizing the use of epidermal growth factor receptor inhibitors in advanced non-small-lung cancer (NSCLC).

Authors:  Emad Shash; Fedro Alessandro Peccatori; Hatem A Azim
Journal:  J Thorac Dis       Date:  2011-03       Impact factor: 2.895

Review 5.  The role of anti-angiogenesis in non-small-cell lung cancer: an update.

Authors:  Liza C Villaruz; Mark A Socinski
Journal:  Curr Oncol Rep       Date:  2015-06       Impact factor: 5.075

Review 6.  Personalizing therapy in advanced non-small cell lung cancer.

Authors:  Liza C Villaruz; Timothy F Burns; Vasilis S Ramfidis; Mark A Socinski
Journal:  Semin Respir Crit Care Med       Date:  2013-11-20       Impact factor: 3.119

Review 7.  Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials.

Authors: 
Journal:  J Clin Oncol       Date:  2008-08-04       Impact factor: 44.544

8.  Expressions of MUC1 and vascular endothelial growth factor mRNA in blood are biomarkers for predicting efficacy of gefitinib treatment in non-small cell lung cancer.

Authors:  Jian Li; Yi-Ming Hu; Yong-Jie Du; Li-Rong Zhu; Hai Qian; Yan Wu; Wei-Lin Shi
Journal:  BMC Cancer       Date:  2014-11-19       Impact factor: 4.430

9.  The Root Extract of Scutellaria baicalensis Induces Apoptosis in EGFR TKI-Resistant Human Lung Cancer Cells by Inactivation of STAT3.

Authors:  Hyun-Ji Park; Shin-Hyung Park; Yung-Hyun Choi; Gyoo-Yong Chi
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 5.923

10.  Erlotinib-induced complete response in a patient with epidermal growth factor receptor wild-type lung adenocarcinoma after chemotherapy failure: a case report.

Authors:  Maria Giuseppa Vitale; Ferdinando Riccardi; Carmela Mocerino; Carmela Barbato; Roberto Monaco; Paola Galloro; Nicola Gagliardi; Giacomo Cartenì
Journal:  J Med Case Rep       Date:  2014-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.